Perspectives of stem cell therapy in Duchenne muscular dystrophy (pages 4251–4262)
Mirella Meregalli, Andrea Farini, Marzia Belicchi, Daniele Parolini, Letizia Cassinelli, Paola Razini, Clementina Sitzia and Yvan Torrente
Version of Record online: 7 JAN 2013 | DOI: 10.1111/febs.12083
Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy and unfortunately no effective therapy is available at present. As stem cells received much attention for their potential use in cell-based therapies for human diseases, herein we described multiple types of resident and circulating myogenic stem cells, their characterization and their possible use to treat muscular dystrophies.